About us
Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here?
Let's talk.
The other half of the equation is
blog posts from readers like you. So if you have an interest in science,
please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our
Privacy Policy and Site Disclaimer.
HERE is a New type of antiviral Medication that kills virus'
and not yet FDA approved but approved in Russia and might cure Swine Flu virus:
NOV-205, a second compound acts as a hepatoprotective agent with immunomodulating and antiinflammatory properties. Novelos’ IND for NOV-205 as mono-therapy for chronic hepatitis C has been accepted by the FDA, and a U.S. Phase 1b trial in patients who previously failed treatment with pegylated interferon plus ribavirin was concluded based on favorable safety profile. Russian clinical studies in hepatitis B and C patients showed that after relatively short treatment periods (1 to 2 months) with NOV-205, viral load was undetectable in a high proportion of patients and serum biochemical markers of liver damage were significantly decreased.
http://www.novelos.com/
Alex Kalman